Inflammation markers on benign breast biopsy are associated with risk of invasive breast cancer in African American women.

Asra N ShaikKatrin KiavashKarri StarkJulie L BoernerJulie J RuterbuschHany DeirawanSudeshna BandyopadhyayRouba Ali-FehmiGregory DysonMichele L Cote

Published in: Breast cancer research and treatment (2020)

CLS-B and IL may serve as histological markers of BrCa risk in benign breast biopsies from AA women.

Keyphrases